TSTL - Ticker AI Digest

Tristel 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (TSTL) 1
TSTL 06:01
Tristel
Additional info. submitted to FDA for Tristel OPH
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Tristel plc, a global infection prevention company, has submitted additional information to the U.S. FDA for Tristel OPH, a high-level disinfectant foam for ophthalmic medical devices. The company expects a decision by the end of June 2025. Tristel OPH aims to address inefficiencies in current decontamination practices and improve disinfection standards for semi-critical ophthalmic devices in the US market. With c.16 million ultrasound procedures annually in North America, FDA clearance is expected to significantly impact ophthalmic disinfection practices. Tristels CEO, Matt Sassone, expresses confidence in the submission and the potential for a positive decision before the APIC conference in mid-June.
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 2
TSTL 06:01
Tristel
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
TSTL 09:31
Tristel
Director/PDMR Shareholding
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 1
TSTL 06:01
Tristel
Additional info. submitted to FDA for Tristel OPH
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Tristel plc, a global infection prevention company, has submitted additional information to the U.S. FDA for Tristel OPH, a high-level disinfectant foam for ophthalmic medical devices. The company expects a decision by the end of June 2025. Tristel OPH aims to address inefficiencies in current decontamination practices and improve disinfection standards for semi-critical ophthalmic devices in the US market. With c.16 million ultrasound procedures annually in North America, FDA clearance is expected to significantly impact ophthalmic disinfection practices. Tristels CEO, Matt Sassone, expresses confidence in the submission and the potential for a positive decision before the APIC conference in mid-June.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 2
TSTL 07:57
Tristel
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
TSTL 13:40
Tristel
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
TSTL 06:01
Tristel
Publication of Poster by Mayo Clinic & US update
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Tristel plc, a manufacturer of infection prevention products, announces the publication of a poster by the Mayo Clinic highlighting the effectiveness of its Tristel ULT product. The poster, presented at a surgical conference, details a 90-day trial where Tristel ULT, a high-level disinfection foam, was used by Mayo Clinic staff to reprocess ultrasound probes with no reported surgical site infections. The method was praised for its efficiency, safety, ease of use, and cost-effectiveness, reducing reprocessing time and minimizing damage to ultrasound probes.
This positive case study adds to the growing adoption of Tristel ULT in North America, with strong sales momentum and increasing customer engagement. The company estimates that Tristel ULT has been used for over 200,000 disinfection procedures in the region. CEO Matt Sassone expresses confidence in the continued momentum and highlights the products US manufacturing, ensuring tariff-resilience.
Tristel plc is a global infection prevention company focused on chlorine dioxide (ClO2) chemistry. With a presence in over 40 countries and a commitment to annual revenue growth and EBITDA margin, the company is well-positioned for continued success in the infection prevention market.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 6
TSTL 06:01
Tristel
Additional info. submitted to FDA for Tristel OPH
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Tristel plc, a global infection prevention company, has submitted additional information to the U.S. FDA for Tristel OPH, a high-level disinfectant foam for ophthalmic medical devices. The company expects a decision by the end of June 2025. Tristel OPH aims to address inefficiencies in current decontamination practices and improve disinfection standards for semi-critical ophthalmic devices in the US market. With c.16 million ultrasound procedures annually in North America, FDA clearance is expected to significantly impact ophthalmic disinfection practices. Tristels CEO, Matt Sassone, expresses confidence in the submission and the potential for a positive decision before the APIC conference in mid-June.
TSTL 06:01
Tristel
Publication of Poster by Mayo Clinic & US update
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Tristel plc, a manufacturer of infection prevention products, announces the publication of a poster by the Mayo Clinic highlighting the effectiveness of its Tristel ULT product. The poster, presented at a surgical conference, details a 90-day trial where Tristel ULT, a high-level disinfection foam, was used by Mayo Clinic staff to reprocess ultrasound probes with no reported surgical site infections. The method was praised for its efficiency, safety, ease of use, and cost-effectiveness, reducing reprocessing time and minimizing damage to ultrasound probes.
This positive case study adds to the growing adoption of Tristel ULT in North America, with strong sales momentum and increasing customer engagement. The company estimates that Tristel ULT has been used for over 200,000 disinfection procedures in the region. CEO Matt Sassone expresses confidence in the continued momentum and highlights the products US manufacturing, ensuring tariff-resilience.
Tristel plc is a global infection prevention company focused on chlorine dioxide (ClO2) chemistry. With a presence in over 40 countries and a commitment to annual revenue growth and EBITDA margin, the company is well-positioned for continued success in the infection prevention market.
TSTL 06:01
Tristel
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
TSTL 07:57
Tristel
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
TSTL 09:31
Tristel
Director/PDMR Shareholding
TSTL 13:40
Tristel
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy

AI Crunch

Single-Ticker AI Crunch
TSTL signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Tristel. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full TSTL AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for TSTL on 2025-04-10.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
177346704
Enterprise Value
152780376
Public Float
96.11
Broker Target
473.333
Shares Out
47931543
Long Interest
80
Short Interest
20
Exchange
LSE
Currency Code
GBX
ISIN
GB00B07RVT99
Market
LSE - AIM
Sector
Health Care Providers
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
0.14
Ex Divi
2026-03-19
Earnings Date
2026-02-23
Net Debt
-2767000.0
Cash
8644000.0
EPS
0.16
Net Income
6640000.0
Revenue
46462000.0
Enterprise Value
152780376
Trailing PE
23.125
Forward PE
19.6078
Price Sales TTM
3.5801
Price Book MRQ
5.4287
EV Revenue
3.5261
EV EBITDA
13.5512

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
26.9427
Institutions As Of
2025-11-12
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
3
Sale Director Dealing
3
Purchase TR1
1
Sale TR1
6
Broker Coverage Rows
3
Institution Holders Tracked
5
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit TSTL.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2025-04-10 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
Tristel has fresh news flow feeding the chart narrative.
AI Charts Studio
TSTL Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-04-10 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 31.15%
RSI Gauge
Price Change
AI Forecast